Stock MET METLIFE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials MetLife, Inc.

Equities

MET

US59156R1086

Life & Health Insurance

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
70.42 USD -2.06% Intraday chart for MetLife, Inc. -0.97% +6.49%
Apr. 23 MetLife Increases Quarterly Dividend to $0.545 Per Share From $0.52, Payable June 11 to Shareholders of Record on May 7 MT
Apr. 23 MetLife Raises Quarterly Dividend by 4.8% DJ

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 46,874 42,253 52,564 56,782 48,949 50,915 - -
Enterprise Value (EV) 1 46,874 42,253 52,564 76,220 56,093 151,507 143,090 153,016
P/E ratio 8.41 x 8.27 x 8.55 x 24.9 x 36.5 x 8.53 x 7.57 x 6.99 x
Yield 3.41% 3.88% 3.04% 2.74% 3.12% 3.06% 3.16% 3.36%
Capitalization / Revenue 0.7 x 0.64 x 0.75 x 0.75 x 0.68 x 0.69 x 0.66 x 0.63 x
EV / Revenue 0.7 x 0.64 x 0.75 x 1.01 x 0.78 x 2.05 x 1.86 x 1.89 x
EV / EBITDA - - - - 6.18 x 17.6 x 18 x -
EV / FCF - - 4.17 x - - 29.1 x 21 x -
FCF Yield - - 24% - - 3.44% 4.76% -
Price to Book 0.74 x 0.6 x 0.81 x 2.43 x 1.84 x 1.81 x 1.61 x 1.44 x
Nbr of stocks (in thousands) 919,631 899,949 841,160 784,606 740,190 723,020 - -
Reference price 2 50.97 46.95 62.49 72.37 66.13 70.42 70.42 70.42
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 66,974 66,465 70,244 75,548 71,715 73,762 76,900 80,932
EBITDA 1 - - - - 9,080 8,607 7,941 -
EBIT 1 7,559 8,120 11,000 8,221 8,362 8,385 8,326 8,666
Operating Margin 11.29% 12.22% 15.66% 10.88% 11.66% 11.37% 10.83% 10.71%
Earnings before Tax (EBT) 1 6,795 6,927 8,126 2,859 2,162 7,981 8,524 9,016
Net income 1 5,721 5,191 6,353 2,354 1,380 5,909 6,313 6,573
Net margin 8.54% 7.81% 9.04% 3.12% 1.92% 8.01% 8.21% 8.12%
EPS 2 6.060 5.680 7.310 2.910 1.810 8.257 9.301 10.07
Free Cash Flow 1 - - 12,596 - - 5,210 6,807 -
FCF margin - - 17.93% - - 7.06% 8.85% -
FCF Conversion (EBITDA) - - - - - 60.53% 85.73% -
FCF Conversion (Net income) - - 198.27% - - 88.17% 107.82% -
Dividend per Share 2 1.740 1.820 1.900 1.980 2.060 2.151 2.224 2.368
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 17,087 20,211 17,724 18,298 23,690 15,836 16,126 18,634 15,866 18,718 17,728 18,277 18,689 19,094 18,683
EBITDA - - - - - - - - - - - - - - -
EBIT 1 2,917 2,353 2,500 2,357 1,576 1,788 1,857 2,221 2,288 1,996 1,831 2,341 2,448 2,521 -
Operating Margin 17.07% 11.64% 14.11% 12.88% 6.65% 11.29% 11.52% 11.92% 14.42% 10.66% 10.33% 12.81% 13.1% 13.2% -
Earnings before Tax (EBT) 1 - 1,306 715 -2 419 1,727 257 430 534 941 1,813 2,007 2,240 2,268 -
Net income 1 1,521 1,176 606 103 331 1,314 14 370 422 574 1,240 1,482 1,552 1,606 1,508
Net margin 8.9% 5.82% 3.42% 0.56% 1.4% 8.3% 0.09% 1.99% 2.66% 3.07% 6.99% 8.11% 8.31% 8.41% 8.07%
EPS 2 1.770 1.390 0.7300 0.1300 0.4100 1.660 0.0200 0.4800 0.5600 0.7700 1.680 2.081 2.194 2.271 2.259
Dividend per Share 2 0.4800 0.4800 0.4800 0.5000 0.5000 0.5000 0.5000 0.5200 - 0.5200 0.5167 0.5383 0.5383 0.5420 0.5400
Announcement Date 11/3/21 2/2/22 5/4/22 8/3/22 11/2/22 2/1/23 5/3/23 8/2/23 11/1/23 1/31/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 19,438 7,144 100,592 92,175 102,100
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - - - 0.7868 x 11.69 x 11.61 x -
Free Cash Flow 1 - - 12,596 - - 5,210 6,807 -
ROE (net income / shareholders' equity) 13.1% 11.9% 16.6% 12.3% 13.6% 14.7% 15.3% 15.5%
ROA (Net income/ Total Assets) 0.8% 0.68% 0.82% 0.78% 0.82% 1.05% 1.1% 1.2%
Assets 1 713,965 767,899 777,411 302,765 168,684 562,734 573,940 547,777
Book Value Per Share 2 68.60 78.70 77.10 29.80 35.90 38.90 43.80 49.00
Cash Flow per Share - 12.70 14.50 16.30 - - - -
Capex 1 - - - - - 2,979 3,066 -
Capex / Sales - - - - - 4.04% 3.99% -
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for MetLife, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
70.42 USD
Average target price
82.31 USD
Spread / Average Target
+16.88%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Life & Health Insurance

1st Jan change Capi.
METLIFE, INC. Stock MetLife, Inc.
+6.49% 50.92B
AFLAC INCORPORATED Stock Aflac Incorporated
+1.35% 48.11B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
+9.53% 42.2B
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
+6.55% 39.71B
GENERALI Stock Generali
+19.34% 37.78B
SUN LIFE FINANCIAL INC. Stock Sun Life Financial Inc.
+2.84% 30.07B
GREAT-WEST LIFECO INC. Stock Great-West Lifeco Inc.
-7.77% 27.56B
PRUDENTIAL PLC Stock Prudential plc
-18.42% 24.71B
CATHAY FINANCIAL HOLDING CO., LTD. Stock Cathay Financial Holding Co., Ltd.
+6.89% 21.99B
DAI-ICHI LIFE HOLDINGS, INC. Stock Dai-ichi Life Holdings, Inc.
+20.69% 21.68B
Other Life & Health Insurance
  1. Stock Market
  2. Equities
  3. MET Stock
  4. Financials MetLife, Inc.